Stella Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9%.

Top 16 shareholders own 51.9% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
33.6%	Stella Chemifa Corporation	11,450,000	JP¥5.9b	0%	no data
9.14%	Nikko Asset Management Co., Ltd.	3,109,500	JP¥1.6b	0%	no data
2.76%	Takuji Nakamura	940,000	JP¥485.0m	0%	no data
1.28%	SBI Holdings Inc., Asset Management Arm	435,000	JP¥224.5m	0%	0.07%
0.94%	au Kabucom Securities Co., Ltd., Asset Management Arm	319,000	JP¥164.6m	0%	0.8%
0.88%	General Incorporated Foundation International Club	300,000	JP¥154.8m	0%	no data
0.82%	Sumitomo Mitsui Financial Group Inc., Asset Management Arm	278,600	JP¥143.8m	0%	no data
0.76%	JPMorgan Chase & Co, Brokerage and Securities Investments	260,000	JP¥134.2m	0%	no data
0.72%	Rakuten Investment Management, Inc.	244,000	JP¥125.9m	0%	0.05%
0.59%	Sumitomo Heavy Industries, Ltd.	200,000	JP¥103.2m	0%	no data
0.33%	Simplex Asset Management Co., Ltd.	111,800	JP¥57.7m	0.09%	0.04%
0.021%	Koki Uehara	7,000	JP¥3.6m	0%	no data
0.015%	Kazumitsu Yabu	5,000	JP¥2.6m	0%	no data
0.0059%	Tomoyuki Asano	2,000	JP¥1.0m	0%	no data
0.0059%	Toshimitsu Hayashi	2,000	JP¥1.0m	0%	no data
0.0026%	Takahiro Kido	900	JP¥463.6k	0%	no data